These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 120665)

  • 1. Effects of a CA-antagonist (prenylamine) on isoproterenol-induced myocardial lesions in the monkey (Cebus paraguayenses). Electrocardiographic and anatomopathological findings.
    Milei J; Vazquez A; Bolomo N
    Acta Cardiol; 1979; 34(6):417-29. PubMed ID: 120665
    [No Abstract]   [Full Text] [Related]  

  • 2. In vitro analysis of Ca-antagonistic effects of prenylamine as mechanisms for its cardiac actions.
    Hashimoto K; Nakagawa Y; Nabata H; Imai S
    Arch Int Pharmacodyn Ther; 1978 Feb; 231(2):212-21. PubMed ID: 646520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ca overload as the determinant factor in the production of catecholamine-induced myocardial lesions.
    Fleckenstein A; Janke J; Döring HJ; Pachinger O
    Recent Adv Stud Cardiac Struct Metab; 1973; 2():455-66. PubMed ID: 4806979
    [No Abstract]   [Full Text] [Related]  

  • 4. Restriction of isoproterenol-induced myocardial Ca uptake and necrotization in rats by a new Ca-antagonistic compound (ethyl-4-(3,4,5-trimethoxycinnamoyl) piperazinyl acetate (Vascordil)).
    Sigel H; Janke J; Fleckenstein A
    Recent Adv Stud Cardiac Struct Metab; 1975; 6():121-6. PubMed ID: 1197874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An overall review on prenylamine mechanisms of action in experimental models of myocardial damage.
    Milei J; Vazquez A; Bolomo NJ
    Cardiology; 1982; 69(4):192-202. PubMed ID: 6293707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prenylamine inhibition of adriamycin-induced myocardiopathy.
    Milei J; Boveris A; Molina H; Llesuy S; Storino R; Milei SE
    Acta Cardiol; 1985; 40(4):383-96. PubMed ID: 3876672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myocardial fiber necrosis due to intracellular Ca overload-a new principle in cardiac pathophysiology.
    Fleckenstein A; Janke J; Döring HJ; Leder O
    Recent Adv Stud Cardiac Struct Metab; 1974; 4():563-80. PubMed ID: 4468468
    [No Abstract]   [Full Text] [Related]  

  • 8. Prenylamine inhibition of isoproterenol induced myocardial lesions. Histochemical and ultrastructural findings.
    Milei J; Nuñez R; Rapaport M
    Acta Cardiol; 1976; 31(5):354-70. PubMed ID: 1088044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Negative inotropic effect of verapamil, nifedipine and prenylamine and its reversal by calcium or isoproterenol.
    Mattiazzi AR; Garay A
    Arch Int Physiol Biochim; 1983 Sep; 91(3):133-44. PubMed ID: 6198983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Parallel influence of isometric tension development and O2 consumption of isolated papillary muscles under the influence of Ca ions, adrenaline, isoproteranol and organic Ca antagonists (iproveratril, D 600, prenylamine)].
    Byon KY; Fleckenstein A
    Pflugers Arch; 1969; 312(1):R8-9. PubMed ID: 5390309
    [No Abstract]   [Full Text] [Related]  

  • 11. [Experimental study of the effects of prenylamine on heart conduction].
    Gilbert JC; Cheymol G
    Therapie; 1974; 29(2):271-9 passim. PubMed ID: 4848728
    [No Abstract]   [Full Text] [Related]  

  • 12. [Selective inhibition of myocardial contractility by competitive divalent Ca++ antagonists (iproveratril, D 600, prenylamine)].
    Fleckenstein A; Tritthart H; Fleckenstein B; Herbst A; Grün G
    Naunyn Schmiedebergs Arch Pharmakol; 1969; 264(3):227-8. PubMed ID: 4242380
    [No Abstract]   [Full Text] [Related]  

  • 13. [Fundamental cardiac and vascular effects of Ca++-antagonistic coronary drugs].
    Fleckenstein A
    Med Klin; 1975 Oct; 70(42):1665-74. PubMed ID: 1102892
    [No Abstract]   [Full Text] [Related]  

  • 14. [Does prenylamine have beta-adrenolytic properties?].
    Boissier JR; Schmitt H; Giudicelli JF; Viars P
    Therapie; 1968; 23(6):1371-81. PubMed ID: 5713558
    [No Abstract]   [Full Text] [Related]  

  • 15. Antagonism of isoproterenol-induced cardiac necrosis in mice by adenosine, dipyridamole and prenylamine.
    Kulkarni DS; Saraf AP
    Indian Heart J; 1978; 30(4):220-3. PubMed ID: 700760
    [No Abstract]   [Full Text] [Related]  

  • 16. Proceedings: Changes in myocardial ultrastructure and autoradiographic 45Ca distribution during isoproterenol-induced cardiac necrotization--prevention by Ca-antagonistic compounds.
    Leder O
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(Suppl):suppl 282:R55. PubMed ID: 4276599
    [No Abstract]   [Full Text] [Related]  

  • 17. Pathogenesis of isoproterenol-induced myocardial lesions: its reation to human 'coagulative myocytolysis'.
    Milei J; Núñez RG; Rapaport M
    Cardiology; 1978; 63(3):139-51. PubMed ID: 639073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myocardial infarction non-invasively induced in rabbits by administering isoproterenol and vasopressin: protective effects exerted by verapamil.
    Pinelli A; Trivulzio S; Tomasoni L; Bertolini B; Brenna S; Bonacina E; Vignati S
    Fundam Clin Pharmacol; 2004 Dec; 18(6):657-67. PubMed ID: 15548237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prevention of isoproterenol-induced lesions in the rat myocardium by prenylamine].
    Milei J; Nuñez R; Rapaport M
    Medicina (B Aires); 1975; 35(5):445-50. PubMed ID: 1214589
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of hypocalcemia on isoproterenol induced cardiotoxicity in dogs.
    Darsinos JT; Karli JN; Stathaki SN; Ziroyannis PN; Pistevos AC; Levis GM; Moulopoulos SD
    Angiology; 1984 Mar; 35(3):152-62. PubMed ID: 6703405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.